NAPHAZOLINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Naphazoline Hydrochloride patents expire, and what generic alternatives are available?
Naphazoline Hydrochloride is a drug marketed by Rising and Altaire Pharms Inc and is included in three NDAs.
The generic ingredient in NAPHAZOLINE HYDROCHLORIDE is naphazoline hydrochloride; pheniramine maleate. There are eight drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride; pheniramine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Naphazoline Hydrochloride
A generic version of NAPHAZOLINE HYDROCHLORIDE was approved as naphazoline hydrochloride; pheniramine maleate by ALTAIRE PHARMS INC on September 27th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NAPHAZOLINE HYDROCHLORIDE?
- What are the global sales for NAPHAZOLINE HYDROCHLORIDE?
- What is Average Wholesale Price for NAPHAZOLINE HYDROCHLORIDE?
Summary for NAPHAZOLINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 91 |
Clinical Trials: | 5 |
Patent Applications: | 1,963 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NAPHAZOLINE HYDROCHLORIDE at DailyMed |
![NAPHAZOLINE HYDROCHLORIDE drug patent expirations Drug patent expirations by year for NAPHAZOLINE HYDROCHLORIDE](/p/graph/s/t/NAPHAZOLINE_HYDROCHLORIDE-patent-expirations.png)
Recent Clinical Trials for NAPHAZOLINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Laboratorios Sophia S.A de C.V. | Phase 1 |
Sanofi | Phase 1 |
EMS | Phase 3 |
Medical Subject Heading (MeSH) Categories for NAPHAZOLINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for NAPHAZOLINE HYDROCHLORIDE
US Patents and Regulatory Information for NAPHAZOLINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rising | NAPHAZOLINE HYDROCHLORIDE | naphazoline hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 083590-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Altaire Pharms Inc | NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE | naphazoline hydrochloride; pheniramine maleate | SOLUTION/DROPS;OPHTHALMIC | 078208-001 | Sep 27, 2010 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Rising | NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE | naphazoline hydrochloride; pheniramine maleate | SOLUTION/DROPS;OPHTHALMIC | 202795-001 | Jan 24, 2013 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |